2015
DOI: 10.5213/inj.2015.19.3.142
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective

Abstract: Interleukin (IL) 33, a member of the IL-1 superfamily, is an “alarmin” protein and is secreted in its active form from damaged cells undergoing necrotic cell death. Mast cells are one of the main effector cell types in allergic disorders. They secrete a variety of mediators, including T helper 2 cytokines. As mast cells have high-affinity IgE receptors (FcεRI) on their surface, they can capture circulating IgE. IgE-bound mast cells degranulate large amounts of histamine, heparin, and proteases when they encoun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 25 publications
(23 citation statements)
references
References 97 publications
(106 reference statements)
0
23
0
Order By: Relevance
“…This is, to our best of knowledge, quite new finding and adds to our better understanding of the pathophysiology of allergic asthma34. Also, it is quite meaningful that hypergravity could possibly be considered as an additional, non-pharmacologic treatment in the management of allergic respiratory disorders.…”
Section: Discussionmentioning
confidence: 81%
“…This is, to our best of knowledge, quite new finding and adds to our better understanding of the pathophysiology of allergic asthma34. Also, it is quite meaningful that hypergravity could possibly be considered as an additional, non-pharmacologic treatment in the management of allergic respiratory disorders.…”
Section: Discussionmentioning
confidence: 81%
“…IL‐33 can serve as a potent activator of MCs and has been reported to promote survival, maturation, migration, adhesion, and the production of several pro‐inflammatory cytokines (eg, IL‐4, IL‐5, IL‐6, IL‐8, and IL‐13) and chemokines (eg, MIP‐1α and MCP‐1) in these cells . In addition, in the presence of SCF, IL‐33 can also induce TNF production in MCs via a MK2/3‐, ERK1/2‐, and PI3K‐dependent pathway .…”
Section: Alarmin Receptorsmentioning
confidence: 99%
“…244 IL-33 can serve as a potent activator of MCs and has been reported to promote survival, maturation, migration, adhesion, and the production of several pro-inflammatory cytokines (eg, IL-4, IL-5, IL-6, IL-8, and IL-13) and chemokines (eg, MIP-1α and MCP-1) in these cells. [250][251][252][253][254][255][256][257][258][259][260] In addition, in the presence of SCF, IL-33 can also induce TNF production in MCs via a MK2/3-, ERK1/2-, and PI3K-dependent pathway. 261 Recently, Taracanova et al have shown that IL-33 and SP together amplify TNF secretion from MCs, which is mediated by the interaction of NK-1R and ST2 receptors.…”
Section: St2/il-33mentioning
confidence: 99%
“…Since mast cells lie underneath the epithelium it is unlikely that these cells make contact with bacteria or their products early in the infection. It is more likely that mast cells are activated by “danger signals” secreted by stressed or damaged epithelial cells such as ATP, IL-33 and β-defensin, all of which are potent mast cell activators (3537). In addition to their role in initiating inflammation during infection, mast cells also appear to be important in establishing homeostasis and accelerating tissue recovery after the infection subsides.…”
Section: Cellular Components Of the Innate Immune Response To Infectionmentioning
confidence: 99%